$UNH · UNITEDHEALTH GROUP INC
UnitedHealth Group filed an 8-K with its Q3 2026 earnings release. Revenue was $112.7B (vs $113.2B YoY), adjusted EPS was $4.69 (vs $2.92 YoY), and the medical care ratio improved to 88.4% from 89.9%. Full-year 2026 adjusted EPS guidance was raised to at least $20.50.
- Q3 2026 revenues of $112.7B vs $113.2B in Q3 2025, a slight decline year-over-year.
- Adjusted EPS of $4.69 beat prior-year $2.92 by 61%, driven by medical cost management and operating efficiencies.
- Medical care ratio improved to 88.4% from 89.9% YoY, aided by $610M in favorable prior-period reserve development.
- Full-year 2026 adjusted EPS guidance raised to at least $20.50, up from prior outlook.
- UnitedHealthcare served 48.3M consumers; Optum cared for over 120M patients and generated $3.7B in earnings.
Extended-hours trading shows UNH at $387.70, up +2.43% vs the regular-session close of $378.52, reflecting a positive initial reaction to the earnings beat and guidance raise.
UNH delivered a 61% YoY adjusted EPS jump, raised full-year guidance, and showed broad-based margin improvement across both UnitedHealthcare and Optum — a strong signal for the managed-care sector.
UNH's MCR improvement to 88.4% and operating cost ratio decline to 12.8% signal industry-leading cost discipline at a time when peers face margin pressure from utilization normalization and regulatory scrutiny.
Medicare Advantage membership contracted by 935,000 since year-end 2025; Medicaid redeterminations drove 85,000 member loss in Community & State. DOJ legal actions concerning Medicare program participation remain an ongoing risk.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.